GZ17‐6.02 initiates DNA damage causing autophagosome‐dependent HDAC degradation resulting in enhanced anti‐PD1 checkpoint inhibitory antibody efficacy
出版年份 2020 全文链接
标题
GZ17‐6.02 initiates DNA damage causing autophagosome‐dependent HDAC degradation resulting in enhanced anti‐PD1 checkpoint inhibitory antibody efficacy
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-01-17
DOI
10.1002/jcp.29464
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Super-enhancers: novel target for pancreatic ductal adenocarcinoma
- (2019) Chandrayee Ghosh et al. Oncotarget
- Antitumor effects of curcumin: A lipid perspective
- (2019) Mehri Bemani Naeini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells
- (2019) Paul Dent et al. ONCOGENE
- The irreversible ERBB1/2/4 inhibitor neratinib interacts with the PARP1 inhibitor niraparib to kill ovarian cancer cells
- (2018) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- Prior exposure of pancreatic tumors to [sorafenib + vorinostat] enhances the efficacy of an anti-PD-1 antibody
- (2018) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- Palbociclib augments Neratinib killing of tumor cells that is further enhanced by HDAC inhibition
- (2018) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- Neratinib augments the lethality of [regorafenib + sildenafil]
- (2018) Laurence Booth et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds
- (2018) Vikalp Vishwakarma et al. Scientific Reports
- Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells
- (2018) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
- (2017) Shuping Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species
- (2017) Jane L. Roberts et al. Oncotarget
- HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo
- (2017) Laurence Booth et al. Oncotarget
- The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo
- (2017) Laurence Booth et al. Oncotarget
- Determining whether curcumin degradation/condensation is actually bioactivation (Review)
- (2016) JERZY JANKUN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers
- (2016) Gary N. Asher et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns
- (2016) Mohammed S. Ali-Shtayeh et al. JOURNAL OF ETHNOPHARMACOLOGY
- Regulation of de novo translation of host cells by manipulation of PERK/PKR and GADD34-PP1 activity during Newcastle disease virus infection
- (2016) Ying Liao et al. JOURNAL OF GENERAL VIROLOGY
- PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide
- (2016) Laurence Booth et al. Oncotarget
- Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells
- (2015) Lei Zhang et al. CANCER BIOLOGY & THERAPY
- OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer Therapies
- (2015) Laurence Booth et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells
- (2014) Jane L Roberts et al. CANCER BIOLOGY & THERAPY
- A Controlled Study of a Lecithinized Delivery System of Curcumin (Meriva®) to Alleviate the Adverse Effects of Cancer Treatment
- (2013) Gianni Belcaro et al. PHYTOTHERAPY RESEARCH
- Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
- (2013) Natalia Realini et al. Scientific Reports
- Oxidative Metabolites of Curcumin Poison Human Type II Topoisomerases
- (2012) Adam C. Ketron et al. BIOCHEMISTRY
- Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation
- (2011) John Cuomo et al. JOURNAL OF NATURAL PRODUCTS
- Insights into the inhibition of xanthine oxidase by curcumin
- (2009) Liang Shen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Contribution of Degradation Products to the Anticancer Activity of Curcumin
- (2009) L. Shen et al. CLINICAL CANCER RESEARCH
- The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells
- (2009) Yonggang Ma et al. PHYTOTHERAPY RESEARCH
- Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
- (2008) S. K. Vareed et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now